Close Menu

NEW YORK – Edan Diagnostics announced on Sunday it has acquired LGC’s Clarilight molecular diagnostics, point-of-care platform for an undisclosed amount.

The two firms have also agreed to partner to develop molecular diagnostic assays designed for Clarilight and for the supply of enzymes and oligonucleotides required for manufacturing. Edan will develop, manufacture, and market the instrument and test cartridges, as well as sell them.

Edan said it anticipates launching its initial products in two to three years.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.